Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
However, insurance plans may cover part or all of the cost
Understanding these diverse effects and optimizing GLP-1 therapies across patient populations is essential and for this, real-world data (RWD) is key
Authors: Karen G Farrar University of Southern California , Los Angeles, CA, Duy Do Truveta, Inc , Bellevue, WA, Nina B Masters Truveta, Inc , Bellevue, WA, Brianna M Cartwright Truveta, Inc , Bellevue, WA After CVS Caremark made anti-obesity semaglutide the preferred formulary option in July 2025, switching from anti-obesity tirzepatide surged from 0.6% to 9.7%, representing more than a 16-fold rise
S., Madeley, J
US$ 25.80
US$ 21.67
US$ 22.64
US$ 24.78
US$ 20.15
US$ 29.86
